Clinical Application of Repurposed Drugs

Erscheinungsjahr 2024
ISBN: 978-0-443-24114-7
Verlag: Elsevier Science & Technology

Buch, Englisch, Format (B × H): 152 mm x 229 mm, Gewicht: 450 g

Clinical Application of Repurposed Drugs, Volume 207 in the Progress in Molecular Biology and Translational Science series, highlights new advances in the field, with this new volume presenting interesting chapters on Drug repurposing for viral disease, Drug repurposing for bacterial infections, Drug repurposing for parasitic protozoan diseases, Drug repurposing for fungal infections, Drug repurposing for treating anxiety and depression, Drug repurposing for personalized medicine, Drug repurposing for cancer, Drug Repurposing: A multi targeted approach to treat cardiac disease from existing classical drugs to modern drug discovery, and much more. Additional chapters cover Drug repurposing in MASLD and MASH-cirrhosis: targets and treatment approaches based on pathways analysis, Drug repurposing for respiratory infections, Drug repurposing for rare disease, Drug repurposing for neurological disorders, Drug repurposing for metabolic disorders: scientific, technological and economic issues, Drug repurposing for regenerative medicine and cosmetics: scientific, technological and economic issues, and Exploring Cutting-Edge Omics-Driven Strategies for Drug Repurposing - An Insight into the Tools of the Trade.

Autoren/Hrsg.

Weitere Mitwirkende

Singh, Vijai

Fachgebiete

• Naturwissenschaften Biowissenschaften Biochemie (nichtmedizinisch)
• Naturwissenschaften Biowissenschaften Molekularbiologie

Inhaltsverzeichnis

Preface
Vijai Singh
1. Drug repurposing for viral disease
Sunday N. Okafor
2. Drug repurposing for bacterial infections
Mustafeez Mujtaba Babar
3. Drug repurposing for parasitic protozoan diseases
Pappachan Anju
4. Drug repurposing for fungal infections
Indra Mani
5. Drug repurposing for treating anxiety and depression
Vijai Singh
6. Drug repurposing for personalised medicine
Indra Mani
7. Drug repurposing for cancer
Shuvomoy Banerjee
8. Drug Repurposing: A multi targetted approach to treat cardiac disease from existing classical drugs to modern drug discovery
Rashmi K. Ambasta
9. Drug repurposing in MASLD and MASH-cirrhosis: targets and treatment approaches based on pathways analysis
Silvia Sookoian and Carlos Pirola
10. Drug repurposing for respiratory infections
Ajay Kumar I
11. Drug repurposing for rare disease
Ajay Kumar I
12. Drug repurposing for neurological disorders
Anand Krishna Tiwari
13. Drug repurposing for metabolic disorders: scientific, technological and economic issues
Dinh -Toi Chu
14. Drug repurposing for regenerative medicine and cosmetics: scientific, technological and economic issues
Dinh -Toi Chu
15. Exploring Cutting-Edge Omics-Driven Strategies for Drug Repurposing - An Insight into the Tools of the Trade
Saraswathy Ganesan Rajalekshmi and Kshreeraja S Satish

Über Autor(innen)

Singh, Vijai
Dr Vijai Singh is a Professor and Dean (Research & Innovation) at School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. He was an Associate Professor in the Department of Biosciences, School of Sciences, Indrashil University, Rajpur, Mehsana, Gujarat, India. Prior this this, he was an Assistant Professor in the Department of Biological Sciences and Biotechnology at the Institute of Advanced Research, Gandhinagar, India and also an Assistant Professor in the Department of Biotechnology at the Invertis University, Bareilly, India. Prior to that, he was a Postdoctoral Fellow in the Synthetic Biology Group at the Institute of Systems and Synthetic Biology, Paris, France and School of Energy & Chemical Engineering at the Ulsan National Institute of Science and Technology, Ulsan, South Korea. He received his Ph.D. in Biotechnology from the National Bureau of Fish Genetic Resources, Uttar Pradesh Technical University, Lucknow, India with a research focus on the development of molecular and immunoassays for diagnosis of Aeromonas hydrophila. His research interests are focused on building novel biosynthetic pathways for production of medically and industrially important biomolecules. Additionally, his laboratory is working on CRISPR-Cas9 tools for genome editing. He has more than 11 years of research and teaching experience in synthetic biology, metabolic engineering, bioinformatics, microbiology, and industrial microbiology. He has published 100 articles, 70 chapters, 15 books and 3 patents. He serves as an associate editor, editorial board member, and reviewer of several peer-reviewed journals. He is also a member of the Board of Study and Academic Council of Indrashil University and is the Member Secretary of the Institutional Biosafety Committee (IBSC) at the same University.